S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Synergy Pharmaceuticals Completes Patient Enrollment for its SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation|
|Synergy Pharmaceuticals Reports Second Quarter and First Half 2014 Financial Results|
|Synergy Pharmaceuticals Reaches Halfway Mark for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation|
|Synergy Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Plecanatide in Irritable Bowel Syndrome with Constipation|
|IBM Ranked Among Top 3 Cloud Providers by Synergy Research|
|Synergy Pharmaceuticals to Present at Canaccord Genuity Growth Conference|
|Nature's Sunshine Announces Strategic Alliance With Fosun Pharma|
|C&J Energy Services to Combine with Nabors' Completion and Production Businesses in Transaction Valued at $2.86 Billion|
|Trimble Acquires Load Systems International to Integrate Crane Safety and Accuracy into Construction Processes|
|Nature's Sunshine Products Reports Second Quarter 2014 Financial Results|
Click above to view more mutual fund data and stats for esyg - e-Synergies Inc.